Company News

L’Oréal USA Inks Deal with Organovo

Will develop 3-D printed skin tissue for product evaluation, research.

Author Image

By: Christine Esposito

Editor-in-Chief

L'Oréal USA has inked a partnership with 3-D bioprinting company Organovo Holdings, Inc. Developed between L'Oréal's U.S.-based global Technology Incubator and Organovo, the collaboration will leverage Organovo's proprietary NovoGen Bioprinting Platform and L'Oreal's expertise in skin engineering to develop 3-D printed skin tissue for product evaluation and other areas of advanced research. Organovo's 3D bioprinting enables the reproducible, automated creation...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters